For more information on BPNSTs, please refer to the Rare Cancers Australia Peripheral Nerve Sheath Tumours (Benign) page
Evidence and Clinical Guidance GLP-1 receptor agonists, primarily prescribed for type 2 diabetes and weight management, have demonstrated modest but consistent improvements in cholesterol and lipid profiles
With the continuous expansion of the North American food and beverage sector, the demand for glutathione is on the rise
There was also a notable increase in healthcare facility referrals, from 23.0% before approval to 33.5% afterward, highlighting that even exposures considered clinically non-severe can drive substantial healthcare utilization
(2011) Angiogenic effects of BPC-157 Hsieh et al
A relatively small difference was observed between the CagriSema and placebo groups in the proportion of participants with resistant hypertension achieving BP targets at week 68 (42.0% and 29.3%, respectively)